[Therapies for synchronous malignomas - the importance of interdisciplinary oncology].

Sarina Müller; Marlen Haderlein; Maximilian Traxdorf; Sabine Semrau; Abbas Agaimy; Sebastian Lettmaier; Antoniu-Oreste Gostian; Christoph Schubart; Konstantinos Mantsopoulos; Daniela Schmidt; Marco Wiesmueller; Matti Sievert; Michael Beck; Markus Eckstein; Rainer Fietkau; Heinrich Iro; Markus Hecht

doi:10.1055/a-1540-7017

[Therapies for synchronous malignomas - the importance of interdisciplinary oncology].

Sarina Müller, Marlen Haderlein, Maximilian Traxdorf (Co-author), Sabine Semrau, Abbas Agaimy, Sebastian Lettmaier, Antoniu-Oreste Gostian, Christoph Schubart, Konstantinos Mantsopoulos, Daniela Schmidt, Marco Wiesmueller, Matti Sievert, Michael Beck, Markus Eckstein, Rainer Fietkau, Heinrich Iro, Markus Hecht

Research output: Contribution to journal › Original Article › peer-review

Original language	German
Pages (from-to)	327-330
Journal	LARYNGO-RHINO-OTOLOGIE
Volume	101
Issue number	4
DOIs	https://doi.org/10.1055/a-1540-7017
Publication status	Published - 2022

Keywords

EML4-ALK FUSION GENE
PRIMARY MALIGNANCIES

Access to Document

10.1055/a-1540-7017

Cite this

Müller, S., Haderlein, M., Traxdorf, M., Semrau, S., Agaimy, A., Lettmaier, S., Gostian, A.-O., Schubart, C., Mantsopoulos, K., Schmidt, D., Wiesmueller, M., Sievert, M., Beck, M., Eckstein, M., Fietkau, R., Iro, H., & Hecht, M. (2022). [Therapies for synchronous malignomas - the importance of interdisciplinary oncology]. LARYNGO-RHINO-OTOLOGIE, 101(4), 327-330. https://doi.org/10.1055/a-1540-7017

@article{443adcae8dd440d48da5f51ab5c9c7f0,

title = "[Therapies for synchronous malignomas - the importance of interdisciplinary oncology].",

keywords = "EML4-ALK FUSION GENE, PRIMARY MALIGNANCIES",

author = "Sarina M{\"u}ller and Marlen Haderlein and Maximilian Traxdorf and Sabine Semrau and Abbas Agaimy and Sebastian Lettmaier and Antoniu-Oreste Gostian and Christoph Schubart and Konstantinos Mantsopoulos and Daniela Schmidt and Marco Wiesmueller and Matti Sievert and Michael Beck and Markus Eckstein and Rainer Fietkau and Heinrich Iro and Markus Hecht",

year = "2022",

doi = "10.1055/a-1540-7017",

language = "Deutsch",

volume = "101",

pages = "327--330",

journal = "LARYNGO-RHINO-OTOLOGIE",

issn = "0935-8943",

number = "4",

}

Müller, S, Haderlein, M, Traxdorf, M, Semrau, S, Agaimy, A, Lettmaier, S, Gostian, A-O, Schubart, C, Mantsopoulos, K, Schmidt, D, Wiesmueller, M, Sievert, M, Beck, M, Eckstein, M, Fietkau, R, Iro, H & Hecht, M 2022, '[Therapies for synchronous malignomas - the importance of interdisciplinary oncology].', LARYNGO-RHINO-OTOLOGIE, vol. 101, no. 4, pp. 327-330. https://doi.org/10.1055/a-1540-7017

TY - JOUR

T1 - [Therapies for synchronous malignomas - the importance of interdisciplinary oncology].

AU - Müller, Sarina

AU - Haderlein, Marlen

AU - Traxdorf, Maximilian

AU - Semrau, Sabine

AU - Agaimy, Abbas

AU - Lettmaier, Sebastian

AU - Gostian, Antoniu-Oreste

AU - Schubart, Christoph

AU - Mantsopoulos, Konstantinos

AU - Schmidt, Daniela

AU - Wiesmueller, Marco

AU - Sievert, Matti

AU - Beck, Michael

AU - Eckstein, Markus

AU - Fietkau, Rainer

AU - Iro, Heinrich

AU - Hecht, Markus

PY - 2022

Y1 - 2022

KW - EML4-ALK FUSION GENE

KW - PRIMARY MALIGNANCIES

U2 - 10.1055/a-1540-7017

DO - 10.1055/a-1540-7017

M3 - Originalarbeit

C2 - 34298563

SN - 0935-8943

VL - 101

SP - 327

EP - 330

JO - LARYNGO-RHINO-OTOLOGIE

JF - LARYNGO-RHINO-OTOLOGIE

IS - 4

ER -